This research report provides a comprehensive analysis of the DNA Repair Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global DNA Repair Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of DNA Repair Drugs, challenges faced by the industry, and potential opportunities for market players.
The global DNA Repair Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The DNA Repair Drugs market presents opportunities for various stakeholders, including Oncological, Stroke. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in DNA Repair Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global DNA Repair Drugs market was valued at US$ 559.9 million in 2023 and is projected to reach US$ 1974.5 million by 2030, at a CAGR of 19.4% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the DNA Repair Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the DNA Repair Drugs market.
Market Overview: The report provides a comprehensive overview of the DNA Repair Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., PARP Inhibitors, Other), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the DNA Repair Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the DNA Repair Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the DNA Repair Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the DNA Repair Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the DNA Repair Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the DNA Repair Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for DNA Repair Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the DNA Repair Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
DNA Repair Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
PARP Inhibitors
Other
Market segment by Application
Oncological
Stroke
Global DNA Repair Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
4SC AG
ARCAGY/ GINECO GROUP
Bristol Myers Squibb
British Columbia Cancer Agency
Cambridge University Hospitals NHS Foundation Trust
Genentech
Georgetown University
German Breast Group
GlaxoSmithKline
Jiangsu Hengrui Medicine
Johnson & Johnson
Jonsson Comprehensive Cancer Center
Karyopharm Therapeutics
KuDOS Pharmaceuticals
National Health Service
National Institutes of Health
Tesaro
Outline of Major Chapters:
Chapter 1: Introduces the definition of DNA Repair Drugs, market overview.
Chapter 2: Global DNA Repair Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of DNA Repair Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of DNA Repair Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global DNA Repair Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 DNA Repair Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global DNA Repair Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global DNA Repair Drugs Overall Market Size
2.1 Global DNA Repair Drugs Market Size: 2023 VS 2030
2.2 Global DNA Repair Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global DNA Repair Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top DNA Repair Drugs Players in Global Market
3.2 Top Global DNA Repair Drugs Companies Ranked by Revenue
3.3 Global DNA Repair Drugs Revenue by Companies
3.4 Global DNA Repair Drugs Sales by Companies
3.5 Global DNA Repair Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 DNA Repair Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers DNA Repair Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 DNA Repair Drugs Players in Global Market
3.8.1 List of Global Tier 1 DNA Repair Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 DNA Repair Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global DNA Repair Drugs Market Size Markets, 2023 & 2030
4.1.2 PARP Inhibitors
4.1.3 Other
4.2 By Type - Global DNA Repair Drugs Revenue & Forecasts
4.2.1 By Type - Global DNA Repair Drugs Revenue, 2019-2024
4.2.2 By Type - Global DNA Repair Drugs Revenue, 2025-2030
4.2.3 By Type - Global DNA Repair Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global DNA Repair Drugs Sales & Forecasts
4.3.1 By Type - Global DNA Repair Drugs Sales, 2019-2024
4.3.2 By Type - Global DNA Repair Drugs Sales, 2025-2030
4.3.3 By Type - Global DNA Repair Drugs Sales Market Share, 2019-2030
4.4 By Type - Global DNA Repair Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global DNA Repair Drugs Market Size, 2023 & 2030
5.1.2 Oncological
5.1.3 Stroke
5.2 By Application - Global DNA Repair Drugs Revenue & Forecasts
5.2.1 By Application - Global DNA Repair Drugs Revenue, 2019-2024
5.2.2 By Application - Global DNA Repair Drugs Revenue, 2025-2030
5.2.3 By Application - Global DNA Repair Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global DNA Repair Drugs Sales & Forecasts
5.3.1 By Application - Global DNA Repair Drugs Sales, 2019-2024
5.3.2 By Application - Global DNA Repair Drugs Sales, 2025-2030
5.3.3 By Application - Global DNA Repair Drugs Sales Market Share, 2019-2030
5.4 By Application - Global DNA Repair Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global DNA Repair Drugs Market Size, 2023 & 2030
6.2 By Region - Global DNA Repair Drugs Revenue & Forecasts
6.2.1 By Region - Global DNA Repair Drugs Revenue, 2019-2024
6.2.2 By Region - Global DNA Repair Drugs Revenue, 2025-2030
6.2.3 By Region - Global DNA Repair Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global DNA Repair Drugs Sales & Forecasts
6.3.1 By Region - Global DNA Repair Drugs Sales, 2019-2024
6.3.2 By Region - Global DNA Repair Drugs Sales, 2025-2030
6.3.3 By Region - Global DNA Repair Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America DNA Repair Drugs Revenue, 2019-2030
6.4.2 By Country - North America DNA Repair Drugs Sales, 2019-2030
6.4.3 US DNA Repair Drugs Market Size, 2019-2030
6.4.4 Canada DNA Repair Drugs Market Size, 2019-2030
6.4.5 Mexico DNA Repair Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe DNA Repair Drugs Revenue, 2019-2030
6.5.2 By Country - Europe DNA Repair Drugs Sales, 2019-2030
6.5.3 Germany DNA Repair Drugs Market Size, 2019-2030
6.5.4 France DNA Repair Drugs Market Size, 2019-2030
6.5.5 U.K. DNA Repair Drugs Market Size, 2019-2030
6.5.6 Italy DNA Repair Drugs Market Size, 2019-2030
6.5.7 Russia DNA Repair Drugs Market Size, 2019-2030
6.5.8 Nordic Countries DNA Repair Drugs Market Size, 2019-2030
6.5.9 Benelux DNA Repair Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia DNA Repair Drugs Revenue, 2019-2030
6.6.2 By Region - Asia DNA Repair Drugs Sales, 2019-2030
6.6.3 China DNA Repair Drugs Market Size, 2019-2030
6.6.4 Japan DNA Repair Drugs Market Size, 2019-2030
6.6.5 South Korea DNA Repair Drugs Market Size, 2019-2030
6.6.6 Southeast Asia DNA Repair Drugs Market Size, 2019-2030
6.6.7 India DNA Repair Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America DNA Repair Drugs Revenue, 2019-2030
6.7.2 By Country - South America DNA Repair Drugs Sales, 2019-2030
6.7.3 Brazil DNA Repair Drugs Market Size, 2019-2030
6.7.4 Argentina DNA Repair Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa DNA Repair Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa DNA Repair Drugs Sales, 2019-2030
6.8.3 Turkey DNA Repair Drugs Market Size, 2019-2030
6.8.4 Israel DNA Repair Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia DNA Repair Drugs Market Size, 2019-2030
6.8.6 UAE DNA Repair Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 4SC AG
7.1.1 4SC AG Company Summary
7.1.2 4SC AG Business Overview
7.1.3 4SC AG DNA Repair Drugs Major Product Offerings
7.1.4 4SC AG DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.1.5 4SC AG Key News & Latest Developments
7.2 ARCAGY/ GINECO GROUP
7.2.1 ARCAGY/ GINECO GROUP Company Summary
7.2.2 ARCAGY/ GINECO GROUP Business Overview
7.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Major Product Offerings
7.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.2.5 ARCAGY/ GINECO GROUP Key News & Latest Developments
7.3 Bristol Myers Squibb
7.3.1 Bristol Myers Squibb Company Summary
7.3.2 Bristol Myers Squibb Business Overview
7.3.3 Bristol Myers Squibb DNA Repair Drugs Major Product Offerings
7.3.4 Bristol Myers Squibb DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Bristol Myers Squibb Key News & Latest Developments
7.4 British Columbia Cancer Agency
7.4.1 British Columbia Cancer Agency Company Summary
7.4.2 British Columbia Cancer Agency Business Overview
7.4.3 British Columbia Cancer Agency DNA Repair Drugs Major Product Offerings
7.4.4 British Columbia Cancer Agency DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.4.5 British Columbia Cancer Agency Key News & Latest Developments
7.5 Cambridge University Hospitals NHS Foundation Trust
7.5.1 Cambridge University Hospitals NHS Foundation Trust Company Summary
7.5.2 Cambridge University Hospitals NHS Foundation Trust Business Overview
7.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Major Product Offerings
7.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Cambridge University Hospitals NHS Foundation Trust Key News & Latest Developments
7.6 Genentech
7.6.1 Genentech Company Summary
7.6.2 Genentech Business Overview
7.6.3 Genentech DNA Repair Drugs Major Product Offerings
7.6.4 Genentech DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Genentech Key News & Latest Developments
7.7 Georgetown University
7.7.1 Georgetown University Company Summary
7.7.2 Georgetown University Business Overview
7.7.3 Georgetown University DNA Repair Drugs Major Product Offerings
7.7.4 Georgetown University DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Georgetown University Key News & Latest Developments
7.8 German Breast Group
7.8.1 German Breast Group Company Summary
7.8.2 German Breast Group Business Overview
7.8.3 German Breast Group DNA Repair Drugs Major Product Offerings
7.8.4 German Breast Group DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.8.5 German Breast Group Key News & Latest Developments
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Company Summary
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline DNA Repair Drugs Major Product Offerings
7.9.4 GlaxoSmithKline DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.9.5 GlaxoSmithKline Key News & Latest Developments
7.10 Jiangsu Hengrui Medicine
7.10.1 Jiangsu Hengrui Medicine Company Summary
7.10.2 Jiangsu Hengrui Medicine Business Overview
7.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Major Product Offerings
7.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Jiangsu Hengrui Medicine Key News & Latest Developments
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Company Summary
7.11.2 Johnson & Johnson Business Overview
7.11.3 Johnson & Johnson DNA Repair Drugs Major Product Offerings
7.11.4 Johnson & Johnson DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.11.5 Johnson & Johnson Key News & Latest Developments
7.12 Jonsson Comprehensive Cancer Center
7.12.1 Jonsson Comprehensive Cancer Center Company Summary
7.12.2 Jonsson Comprehensive Cancer Center Business Overview
7.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Major Product Offerings
7.12.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.12.5 Jonsson Comprehensive Cancer Center Key News & Latest Developments
7.13 Karyopharm Therapeutics
7.13.1 Karyopharm Therapeutics Company Summary
7.13.2 Karyopharm Therapeutics Business Overview
7.13.3 Karyopharm Therapeutics DNA Repair Drugs Major Product Offerings
7.13.4 Karyopharm Therapeutics DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.13.5 Karyopharm Therapeutics Key News & Latest Developments
7.14 KuDOS Pharmaceuticals
7.14.1 KuDOS Pharmaceuticals Company Summary
7.14.2 KuDOS Pharmaceuticals Business Overview
7.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Major Product Offerings
7.14.4 KuDOS Pharmaceuticals DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.14.5 KuDOS Pharmaceuticals Key News & Latest Developments
7.15 National Health Service
7.15.1 National Health Service Company Summary
7.15.2 National Health Service Business Overview
7.15.3 National Health Service DNA Repair Drugs Major Product Offerings
7.15.4 National Health Service DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.15.5 National Health Service Key News & Latest Developments
7.16 National Institutes of Health
7.16.1 National Institutes of Health Company Summary
7.16.2 National Institutes of Health Business Overview
7.16.3 National Institutes of Health DNA Repair Drugs Major Product Offerings
7.16.4 National Institutes of Health DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.16.5 National Institutes of Health Key News & Latest Developments
7.17 Tesaro
7.17.1 Tesaro Company Summary
7.17.2 Tesaro Business Overview
7.17.3 Tesaro DNA Repair Drugs Major Product Offerings
7.17.4 Tesaro DNA Repair Drugs Sales and Revenue in Global (2019-2024)
7.17.5 Tesaro Key News & Latest Developments
8 Global DNA Repair Drugs Production Capacity, Analysis
8.1 Global DNA Repair Drugs Production Capacity, 2019-2030
8.2 DNA Repair Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global DNA Repair Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 DNA Repair Drugs Supply Chain Analysis
10.1 DNA Repair Drugs Industry Value Chain
10.2 DNA Repair Drugs Upstream Market
10.3 DNA Repair Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 DNA Repair Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of DNA Repair Drugs in Global Market
Table 2. Top DNA Repair Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global DNA Repair Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global DNA Repair Drugs Revenue Share by Companies, 2019-2024
Table 5. Global DNA Repair Drugs Sales by Companies, (K Units), 2019-2024
Table 6. Global DNA Repair Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers DNA Repair Drugs Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers DNA Repair Drugs Product Type
Table 9. List of Global Tier 1 DNA Repair Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 DNA Repair Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global DNA Repair Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global DNA Repair Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global DNA Repair Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global DNA Repair Drugs Sales (K Units), 2019-2024
Table 15. By Type - Global DNA Repair Drugs Sales (K Units), 2025-2030
Table 16. By Application ? Global DNA Repair Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global DNA Repair Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global DNA Repair Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global DNA Repair Drugs Sales (K Units), 2019-2024
Table 20. By Application - Global DNA Repair Drugs Sales (K Units), 2025-2030
Table 21. By Region ? Global DNA Repair Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global DNA Repair Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global DNA Repair Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global DNA Repair Drugs Sales (K Units), 2019-2024
Table 25. By Region - Global DNA Repair Drugs Sales (K Units), 2025-2030
Table 26. By Country - North America DNA Repair Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America DNA Repair Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America DNA Repair Drugs Sales, (K Units), 2019-2024
Table 29. By Country - North America DNA Repair Drugs Sales, (K Units), 2025-2030
Table 30. By Country - Europe DNA Repair Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe DNA Repair Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe DNA Repair Drugs Sales, (K Units), 2019-2024
Table 33. By Country - Europe DNA Repair Drugs Sales, (K Units), 2025-2030
Table 34. By Region - Asia DNA Repair Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia DNA Repair Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia DNA Repair Drugs Sales, (K Units), 2019-2024
Table 37. By Region - Asia DNA Repair Drugs Sales, (K Units), 2025-2030
Table 38. By Country - South America DNA Repair Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America DNA Repair Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America DNA Repair Drugs Sales, (K Units), 2019-2024
Table 41. By Country - South America DNA Repair Drugs Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa DNA Repair Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa DNA Repair Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa DNA Repair Drugs Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa DNA Repair Drugs Sales, (K Units), 2025-2030
Table 46. 4SC AG Company Summary
Table 47. 4SC AG DNA Repair Drugs Product Offerings
Table 48. 4SC AG DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. 4SC AG Key News & Latest Developments
Table 50. ARCAGY/ GINECO GROUP Company Summary
Table 51. ARCAGY/ GINECO GROUP DNA Repair Drugs Product Offerings
Table 52. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. ARCAGY/ GINECO GROUP Key News & Latest Developments
Table 54. Bristol Myers Squibb Company Summary
Table 55. Bristol Myers Squibb DNA Repair Drugs Product Offerings
Table 56. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Bristol Myers Squibb Key News & Latest Developments
Table 58. British Columbia Cancer Agency Company Summary
Table 59. British Columbia Cancer Agency DNA Repair Drugs Product Offerings
Table 60. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. British Columbia Cancer Agency Key News & Latest Developments
Table 62. Cambridge University Hospitals NHS Foundation Trust Company Summary
Table 63. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Offerings
Table 64. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Cambridge University Hospitals NHS Foundation Trust Key News & Latest Developments
Table 66. Genentech Company Summary
Table 67. Genentech DNA Repair Drugs Product Offerings
Table 68. Genentech DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Genentech Key News & Latest Developments
Table 70. Georgetown University Company Summary
Table 71. Georgetown University DNA Repair Drugs Product Offerings
Table 72. Georgetown University DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Georgetown University Key News & Latest Developments
Table 74. German Breast Group Company Summary
Table 75. German Breast Group DNA Repair Drugs Product Offerings
Table 76. German Breast Group DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. German Breast Group Key News & Latest Developments
Table 78. GlaxoSmithKline Company Summary
Table 79. GlaxoSmithKline DNA Repair Drugs Product Offerings
Table 80. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. GlaxoSmithKline Key News & Latest Developments
Table 82. Jiangsu Hengrui Medicine Company Summary
Table 83. Jiangsu Hengrui Medicine DNA Repair Drugs Product Offerings
Table 84. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 85. Jiangsu Hengrui Medicine Key News & Latest Developments
Table 86. Johnson & Johnson Company Summary
Table 87. Johnson & Johnson DNA Repair Drugs Product Offerings
Table 88. Johnson & Johnson DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 89. Johnson & Johnson Key News & Latest Developments
Table 90. Jonsson Comprehensive Cancer Center Company Summary
Table 91. Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Offerings
Table 92. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 93. Jonsson Comprehensive Cancer Center Key News & Latest Developments
Table 94. Karyopharm Therapeutics Company Summary
Table 95. Karyopharm Therapeutics DNA Repair Drugs Product Offerings
Table 96. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 97. Karyopharm Therapeutics Key News & Latest Developments
Table 98. KuDOS Pharmaceuticals Company Summary
Table 99. KuDOS Pharmaceuticals DNA Repair Drugs Product Offerings
Table 100. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 101. KuDOS Pharmaceuticals Key News & Latest Developments
Table 102. National Health Service Company Summary
Table 103. National Health Service DNA Repair Drugs Product Offerings
Table 104. National Health Service DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 105. National Health Service Key News & Latest Developments
Table 106. National Institutes of Health Company Summary
Table 107. National Institutes of Health DNA Repair Drugs Product Offerings
Table 108. National Institutes of Health DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 109. National Institutes of Health Key News & Latest Developments
Table 110. Tesaro Company Summary
Table 111. Tesaro DNA Repair Drugs Product Offerings
Table 112. Tesaro DNA Repair Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 113. Tesaro Key News & Latest Developments
Table 114. DNA Repair Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 115. Global DNA Repair Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 116. Global DNA Repair Drugs Production by Region, 2019-2024 (K Units)
Table 117. Global DNA Repair Drugs Production by Region, 2025-2030 (K Units)
Table 118. DNA Repair Drugs Market Opportunities & Trends in Global Market
Table 119. DNA Repair Drugs Market Drivers in Global Market
Table 120. DNA Repair Drugs Market Restraints in Global Market
Table 121. DNA Repair Drugs Raw Materials
Table 122. DNA Repair Drugs Raw Materials Suppliers in Global Market
Table 123. Typical DNA Repair Drugs Downstream
Table 124. DNA Repair Drugs Downstream Clients in Global Market
Table 125. DNA Repair Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. DNA Repair Drugs Segment by Type in 2023
Figure 2. DNA Repair Drugs Segment by Application in 2023
Figure 3. Global DNA Repair Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global DNA Repair Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global DNA Repair Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. DNA Repair Drugs Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by DNA Repair Drugs Revenue in 2023
Figure 9. By Type - Global DNA Repair Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global DNA Repair Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global DNA Repair Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global DNA Repair Drugs Price (USD/Unit), 2019-2030
Figure 13. By Application - Global DNA Repair Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global DNA Repair Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global DNA Repair Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global DNA Repair Drugs Price (USD/Unit), 2019-2030
Figure 17. By Region - Global DNA Repair Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global DNA Repair Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global DNA Repair Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global DNA Repair Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America DNA Repair Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America DNA Repair Drugs Sales Market Share, 2019-2030
Figure 23. US DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe DNA Repair Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe DNA Repair Drugs Sales Market Share, 2019-2030
Figure 28. Germany DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia DNA Repair Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia DNA Repair Drugs Sales Market Share, 2019-2030
Figure 37. China DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America DNA Repair Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America DNA Repair Drugs Sales Market Share, 2019-2030
Figure 44. Brazil DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa DNA Repair Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa DNA Repair Drugs Sales Market Share, 2019-2030
Figure 48. Turkey DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE DNA Repair Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global DNA Repair Drugs Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production DNA Repair Drugs by Region, 2023 VS 2030
Figure 54. DNA Repair Drugs Industry Value Chain
Figure 55. Marketing Channels
